Magdaléna Májeková

1.4k total citations
57 papers, 1.1k citations indexed

About

Magdaléna Májeková is a scholar working on Molecular Biology, Organic Chemistry and Cell Biology. According to data from OpenAlex, Magdaléna Májeková has authored 57 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 22 papers in Organic Chemistry and 15 papers in Cell Biology. Recurrent topics in Magdaléna Májeková's work include Aldose Reductase and Taurine (13 papers), Free Radicals and Antioxidants (11 papers) and Bioactive Compounds and Antitumor Agents (10 papers). Magdaléna Májeková is often cited by papers focused on Aldose Reductase and Taurine (13 papers), Free Radicals and Antioxidants (11 papers) and Bioactive Compounds and Antitumor Agents (10 papers). Magdaléna Májeková collaborates with scholars based in Slovakia, Czechia and United Kingdom. Magdaléna Májeková's co-authors include Milan Štefek, Lucia Račková, Daniela Košťálová, Marta Šoltésová Prnová, Jana Viskupičová, Ľubica Horáková, Stanislav Miertuš, Miriam Štrosová, Rona R. Ramsay and Milagros Medina and has published in prestigious journals such as Free Radical Biology and Medicine, International Journal of Molecular Sciences and Journal of Medicinal Chemistry.

In The Last Decade

Magdaléna Májeková

53 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Magdaléna Májeková Slovakia 17 379 291 211 206 160 57 1.1k
Birgit Kraus Germany 19 520 1.4× 249 0.9× 382 1.8× 173 0.8× 67 0.4× 33 1.2k
Vassilis J. Demopoulos Greece 21 468 1.2× 491 1.7× 157 0.7× 537 2.6× 81 0.5× 75 1.4k
Fabio Fusi Italy 27 928 2.4× 342 1.2× 256 1.2× 107 0.5× 286 1.8× 112 2.0k
Ho Sik Rho South Korea 26 679 1.8× 581 2.0× 140 0.7× 291 1.4× 245 1.5× 62 1.8k
Huey-Jiun Ko Taiwan 26 785 2.1× 501 1.7× 344 1.6× 102 0.5× 167 1.0× 57 1.9k
Masayuki Ninomiya Japan 22 509 1.3× 652 2.2× 153 0.7× 58 0.3× 138 0.9× 88 1.5k
Jean‐Pierre Perchellet United States 27 950 2.5× 447 1.5× 159 0.8× 67 0.3× 263 1.6× 76 1.9k
Wolfgang Bicker Austria 26 753 2.0× 89 0.3× 208 1.0× 62 0.3× 85 0.5× 41 2.1k
Ramadan Musa Israel 13 265 0.7× 250 0.9× 175 0.8× 491 2.4× 443 2.8× 14 1.3k
Rosaria Medda Italy 24 1.0k 2.8× 234 0.8× 184 0.9× 209 1.0× 184 1.1× 105 1.9k

Countries citing papers authored by Magdaléna Májeková

Since Specialization
Citations

This map shows the geographic impact of Magdaléna Májeková's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Magdaléna Májeková with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Magdaléna Májeková more than expected).

Fields of papers citing papers by Magdaléna Májeková

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Magdaléna Májeková. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Magdaléna Májeková. The network helps show where Magdaléna Májeková may publish in the future.

Co-authorship network of co-authors of Magdaléna Májeková

This figure shows the co-authorship network connecting the top 25 collaborators of Magdaléna Májeková. A scholar is included among the top collaborators of Magdaléna Májeková based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Magdaléna Májeková. Magdaléna Májeková is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Májeková, Magdaléna, et al.. (2024). Polyphenolic Compounds Activate SERCA1a and Attenuate Methylglyoxal- and Palmitate-Induced Impairment in Pancreatic INS-1E Beta Cells. Cells. 13(22). 1860–1860. 4 indexed citations
2.
Viskupičová, Jana, et al.. (2023). Inhibitors of SARS-CoV-2 main protease: Biological efficacy and toxicity aspects. Toxicology in Vitro. 92. 105640–105640. 3 indexed citations
3.
Viskupičová, Jana, et al.. (2023). Interaction of quercetin and its derivatives with Ca2+-ATPase from sarcoplasmic reticulum: Kinetic and molecular modeling studies. General Physiology and Biophysics. 42(5). 457–468. 3 indexed citations
4.
Hricovı́ni, Miloš, Raymond J. Owens, Andrzej Bąk, et al.. (2022). Chemistry towards Biology—Instruct: Snapshot. International Journal of Molecular Sciences. 23(23). 14815–14815.
5.
Kučerová-Chlupáčová, Marta, et al.. (2020). (4-Oxo-2-thioxothiazolidin-3-yl)acetic acids as potent and selective aldose reductase inhibitors. Chemico-Biological Interactions. 332. 109286–109286. 14 indexed citations
6.
Prnová, Marta Šoltésová, et al.. (2017). Does Inhibition of Aldose Reductase Contribute to the Anti-Inflammatory Action of Setipiprant?. Physiological Research. 66(4). 687–693. 6 indexed citations
7.
Ramsay, Rona R., Magdaléna Májeková, Milagros Medina, & Massimo Valoti. (2016). Key Targets for Multi-Target Ligands Designed to Combat Neurodegeneration. Frontiers in Neuroscience. 10. 375–375. 59 indexed citations
8.
Prnová, Marta Šoltésová, Magdaléna Májeková, Beatriz Díez-Dacal, et al.. (2015). [5-(Benzyloxy)-1H-indol-1-yl]acetic acid, an aldose reductase inhibitor and PPARγ ligand. Acta Biochimica Polonica. 62(3). 523–528. 8 indexed citations
9.
Štefek, Milan, et al.. (2015). Identification of Novel Aldose Reductase Inhibitors Based on Carboxymethylated Mercaptotriazinoindole Scaffold. Journal of Medicinal Chemistry. 58(6). 2649–2657. 45 indexed citations
10.
Viskupičová, Jana, Magdaléna Májeková, & Ľubica Horáková. (2014). Inhibition of the sarco/endoplasmic reticulum Ca2+-ATPase (SERCA1) by rutin derivatives. Journal of Muscle Research and Cell Motility. 36(2). 183–194. 11 indexed citations
11.
Kováčiková, Lucia, Magdaléna Májeková, & Milan Štefek. (2014). Substituted Pyridoindoles as Biological Antioxidants: Drug Design, Chemical Synthesis, and Biological Activity. Methods in molecular biology. 1208. 313–327. 6 indexed citations
12.
Prnová, Marta Šoltésová, Magdaléna Májeková, R Sotníková, et al.. (2014). 2-Chloro-1,4-naphthoquinone derivative of quercetin as an inhibitor of aldose reductase and anti-inflammatory agent. Journal of Enzyme Inhibition and Medicinal Chemistry. 30(1). 107–113. 38 indexed citations
13.
Májeková, Magdaléna, et al.. (2011). Substituted derivatives of indole acetic acid as aldose reductase inhibitors with antioxidant activity: structure-activity relationship. General Physiology and Biophysics. 30(4). 342–349. 11 indexed citations
14.
Augustyniak, Agnieszka, Grzegorz Bartosz, Ana Čipak Gašparović, et al.. (2010). Natural and synthetic antioxidants: An updated overview. Free Radical Research. 44(10). 1216–1262. 253 indexed citations
15.
16.
Májeková, Magdaléna, et al.. (2006). Skin Permeation of Acyl Derivatives of Stobadine. Drug Delivery. 13(1). 51–54.
17.
Štolc, Svorad, et al.. (2006). Development of the New Group of Indole-Derived Neuroprotective Drugs Affecting Oxidative Stress. Cellular and Molecular Neurobiology. 26(7-8). 1493–1502. 30 indexed citations
18.
Račková, Lucia, et al.. (2005). Oxidation of liposomal membrane suppressed by flavonoids: Quantitative structure–activity relationship. Bioorganic & Medicinal Chemistry. 13(23). 6477–6484. 51 indexed citations
19.
Račková, Lucia, Milan Štefek, & Magdaléna Májeková. (2002). Structural aspects of antioxidant activity of substituted pyridoindoles. Redox Report. 7(4). 207–214. 29 indexed citations
20.
Jančinová, Viera, M. Petríková, Magdaléna Májeková, & R. Nosáľ. (1995). Effect of pheniramine, chlorpheniramine and brompheniramine on stimulated blood platelets: Structure-activity relationships. Inflammation Research. 44(S1). S38–S39. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Birgit Kraus Breakdown of academic impact, for papers by Vassilis J. Demopoulos Breakdown of academic impact, for papers by Fabio Fusi Breakdown of academic impact, for papers by Ho Sik Rho Breakdown of academic impact, for papers by Huey-Jiun Ko Breakdown of academic impact, for papers by Masayuki Ninomiya Breakdown of academic impact, for papers by Jean‐Pierre Perchellet Breakdown of academic impact, for papers by Wolfgang Bicker Breakdown of academic impact, for papers by Ramadan Musa Breakdown of academic impact, for papers by Rosaria Medda
Rankless by CCL
2026